14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Sep 28, 2023 Buy 49 350 Fitzgerald Thomas A Common Stock
Sep 28, 2023 Buy 98 000 Dudley Robert Michael Common Stock
Jun 21, 2023 Buy 12 000 Dudley Robert Michael Common Stock
Jun 20, 2023 Buy 6 607 Dudley Robert Michael Common Stock
Jun 09, 2023 Buy 19 000 Dudley Robert Michael Common Stock
Jun 09, 2023 Buy 19 000 Dudley Robert Michael Common Stock
May 19, 2023 Buy 45 000 Manting Erik Stock Option (right to buy)
May 19, 2023 Buy 45 000 Marquet Magda Stock Option (right to buy)
May 19, 2023 Buy 300 000 Fitzgerald Thomas A Stock Option (right to buy)
May 19, 2023 Buy 735 000 Dudley Robert Michael Stock Option (right to buy)
May 19, 2023 Buy 45 000 Calais Philippe Stock Option (right to buy)
May 10, 2023 Buy 9 500 Manting Erik Stock Option (Right to Buy)
May 10, 2023 Buy 9 500 Marquet Magda Stock Option (Right to Buy)
May 10, 2023 Buy 9 500 Calais Philippe Stock Option (Right to Buy)
Dec 12, 2022 Buy 100 000 Fitzgerald Thomas A Stock Option (Right to Buy)
Dec 12, 2022 Buy 135 000 Dudley Robert Michael Stock Option (Right to Buy)
Dec 12, 2022 Buy 60 000 Medarova Zdravka Stock Option (Right to Buy)
Sep 14, 2022 Buy 20 000 Dudley Robert Michael Common Stock
Jun 22, 2022 Buy 9 500 Calais Philippe Stock Option (Right to Buy)
Jun 22, 2022 Buy 9 500 Marquet Magda Stock Option (Right to Buy)
Jun 22, 2022 Buy 9 500 Marquet Magda Stock Option (Right to Buy)
Jun 22, 2022 Buy 9 500 Manting Erik Stock Option (Right to Buy)
Jun 16, 2022 Buy 12 000 Fitzgerald Thomas A Common Stock
May 27, 2022 Buy 28 000 Dudley Robert Michael Common Stock
Mar 01, 2022 Buy 52 000 Fitzgerald Thomas A Stock Option (Right to Buy)
Feb 01, 2022 Buy 33 000 Medarova Zdravka Stock Option (Right to Buy)
Feb 01, 2022 Buy 33 000 Fitzgerald Thomas A Stock Option (Right to Buy)
Feb 01, 2022 Buy 135 000 Dudley Robert Michael Stock Option (Right to Buy)
Jul 08, 2021 Buy 0 Dudley Robert Michael Common Stock
Jul 08, 2021 Buy 818 852 Dudley Robert Michael Stock Option (Right to Buy)
Jul 08, 2021 Buy 0 Fitzgerald Thomas A Common Stock
Jul 08, 2021 Buy 242 622 Fitzgerald Thomas A Stock Option (Right to Buy)
Jul 08, 2021 Buy 36 393 Manting Erik Stock Option (Right to Buy)
Jul 08, 2021 Buy 0 Calais Philippe Common Stock
Jul 08, 2021 Buy 36 393 Calais Philippe Stock Option (Right to Buy)
Jul 08, 2021 Buy 36 393 Marquet Magda Stock Option (Right to Buy)
INSIDER POWER
70.661
Last 36 transactions
Buy: 3 219 110 | Sell: 0 (Shares)

Based on the 36 latest insides trades, we have calculated the insider power to be positive at a ratio of 70.661.

In total, the insiders bought 3 219 110 and sold 0 RNAZ shares in the last 36 trades.

Click to get the best stock tips daily for free!

About TransCode Therapeutics, Inc.

TransCode Therapeutics. TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company's products in preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1; TTX-siLIN28B, an siRNA-based inh... RNAZ Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT